 |
SAMBA -
Professional Info
20TH ANNUAL MEETING ABSTRACTS
|
 |
 |
Treatment of Intractable Pain in a Patient with Neurofibromatosis I: Case Report
Gentian Meta, M.D., Ahmed Ghaleb, M.D.,
Dept. of Anesthesiology, Univ. of Arkansas for Medical Sciences, Little Rock, Arkansas
Introduction
Neurofibromatosis I, also known as Von Recklinghausen’s disease, is an autosomal dominant disease
affecting the nervous system. One of the manifestations of NF1 is the formation of specific peripheral
neurofibromas. We present a case with failed symptomatology after surgical intervention and improvement
after epidural steroid injection.
Case report
Patient is a 38 year-old female with Type I neurofibromatosis (NF1). She presented with severe
radicular pain in her RLE and underwent R partial L5 hemi-laminectomy and nerve root tumor excision.
Surgical intervention failed to relieve her pain, so she was referred to our clinic for pain control. We
performed coccygeal and S1 transforaminal epidural steroid injections resulting in a significant
improvement of her symptoms.
Discussion
NF1 is now recognized as a single gene defect (localized to chromosome 17q11.2) affecting multiple organ systems with a particular predisposition for the formation of specific peripheral neurofibromas. These lesions are benign peripheral nerve sheath tumors characterized by unpredictable growth patterns,
diverse appearances and a variable cellular composition. Neurofibromas are composed of a mixture of cell
types including Schwann cells, fibroblasts, mast cells, and vascular elements. Some patients have painful
neurofibromas along the course of peripheral nerves, which can be difficult to manage surgically. There are
also spinal neurofibromas arising from the dorsal nerve roots, which can lead to pain as well as
neurological deficits. Discrete neurofibromas can be surgically removed, but may develop again in the
same site after surgery. Based on the above statements and knowing that hormonal changes have an effect
on the disease, we hypothesized that steroids could be beneficial in these patients for two reasons. First,
steroids are hormones that could have an effect on the disease. Second, steroids could also affect the
activity of the mixed cells forming the neurofibromas. In addition, surgical excision is invasive and
associated with recurrence while steroid treatment is less invasive and could be beneficial.
The above hypotheses have not been proven in clinical studies. The management of patients affected
with NF1 often requires the cooperation of many medical and surgical sub specialists.
Summary
Neurofibromatosis I is one of the most common genetic conditions affecting the nervous system.
Individuals with NF1 have a predisposition to develop peripheral nerve sheath tumors leading to pain.
Surgical intervention has been used for excruciating pain due to myelopathy or radiculopathy. Whether
steroids are beneficial in the treatment of symptoms or even the neurofibroma itself remains to be proven in
clinical studies.
TOP

© SOCIETY FOR AMBULATORY ANESTHESIA
520
N. Northwest Highway Park Ridge, Illinois 60068-2573
Tel: (847) 825-5586 Fax: (847) 825-5658
E-mail: samba@asahq.org
|